- Associated Press - Friday, October 3, 2014

BRUSSELS (AP) - The European Union’s antitrust authority says it has approved the $5.4 billion sale of Novartis’ animal health division to U.S. pharmaceutical firm Eli Lilly.

The 28-nation bloc’s executive Commission said Friday the sale won’t hinder competition because the merged firm will continue to face a number of strong competitors.

Switzerland-based Novartis AG in April launched a major overhaul of its business which included the sale of the animal health division.

Indianapolis-based Eli Lilly & Co. has been hit hard by patent expirations and has staked its recovery in part on new drugs it develops and its animal health business.



Click to Read More

Click to Hide